PIC/S GDP and Pharmaceutical Distribution Quality: Why It Matters for ASEAN Importers Beyond GMP

Why the Quality Chain Doesn't End at the Factory Gate

Most discussions of pharmaceutical export quality focus on GMP — the manufacturing standard. But a product manufactured under strict GMP conditions can still be compromised after it leaves the factory: through improper storage temperature, mishandled transit, broken cold chains, or poor documentation during the journey from Taiwan to an ASEAN warehouse.

This is the role of GDP — Good Distribution Practice. Where GMP governs how a product is made, GDP governs how it is stored, handled, and transported after manufacturing, until it reaches the importer.

What PIC/S GDP Certification Covers

A PIC/S GDP-certified entity must demonstrate documented, auditable control over:

• →Storage conditions: Temperature-monitored warehousing appropriate to each product's stability requirements
• →Transport integrity: Validated cold chain (2–8°C) or controlled room temperature shipping, with continuous temperature logging
• →Batch traceability: Full chain-of-custody documentation from receipt through final shipment
• →Quality agreements: Documented responsibilities between manufacturer, distributor, and importer
• →Deviation handling: Documented procedures for temperature excursions, damaged shipments, or handling incidents

Where GDP Risk Concentrates: Cold Chain Products

Not all pharmaceutical products carry equal GDP risk. Products requiring 2–8°C storage — many injectables, biologics, and certain liquid formulations — are the most vulnerable to distribution-stage quality failures. A single unlogged temperature excursion during the multi-leg export journey can compromise product efficacy without any visible sign of damage.

For importers, this makes continuous, documented temperature logging across the entire journey — not just at the factory — a critical verification point.

GDP and GMP Are Complementary, Not Interchangeable

Importers evaluating a Taiwan supply chain should confirm both:

• →Is the manufacturing site PIC/S GMP certified?
• →Is the party responsible for storage, consolidation, and export logistics PIC/S GDP certified?

A gap in either link weakens the overall quality assurance of the supply chain — regardless of how strong the other link is.

What Importers Should Ask an Export Partner

• →Does the export partner hold current PIC/S GDP certification, and for which activities (storage, transport, distribution)?
• →Is temperature data logged and available for review for cold chain shipments?
• →What is the documented procedure if a temperature excursion or shipping delay occurs?
• →How is batch traceability maintained from the manufacturer through to delivery?

Summary

GMP certification confirms a product was manufactured correctly. GDP certification confirms it stayed that way on its way to the importer. For ASEAN pharmaceutical buyers, verifying both — manufacturing quality and distribution quality — provides a more complete picture of supply chain risk than checking manufacturing credentials alone.